SCHEMBL1714974

SCHEMBL1714974

CC(=O)Oc1ccc(C(F)(F)F)cc1F

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.62
CYP2C19 P33261 2/20 0.62
ALDH1A1 P00352 2/20 0.62
HPGD P15428 2/20 0.62
USP2 O75604 1/20 0.62
HSD17B10 Q99714 1/20 0.62
BACE1 P56817 1/20 0.54
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP4F2 P78329 1/20 0.45
CYP4A11 Q02928 1/20 0.45
PDE2A O00408 2/20 0.44
GAA P10253 2/20 0.43
TSHR P16473 1/20 0.42
RAB9A P51151 1/20 0.42
CFD P00746 1/20 0.41
APP P05067 1/20 0.41
CFTR P13569 1/20 0.41
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4976918 0.86 CYP2C19 (0.67) KDM4ECYP2C19ALDH1A1HPGDUSP2
SCHEMBL17356412 0.83 CYP2C19 (0.47) KDM4ECYP2C19ALDH1A1HPGDUSP2
SCHEMBL4981997 0.83 KDM4E (0.62) KDM4ECYP2C19ALDH1A1HPGDUSP2
SCHEMBL24436827 0.83 KDM4E (0.62) KDM4ECYP2C19ALDH1A1HPGDUSP2
SCHEMBL29188533 0.83 KIF11 (0.51) KDM4ECYP2C19ALDH1A1HPGDUSP2
SCHEMBL17356510 0.82 CFTR (0.44) KDM4ECYP2C19ALDH1A1HPGDUSP2
SCHEMBL2183270 0.81 CYP2C19 (0.60) KDM4ECYP2C19ALDH1A1HPGDUSP2
SCHEMBL5769694 0.81 KDM4E (0.60) KDM4ECYP2C19ALDH1A1HPGDUSP2
SCHEMBL13163891 0.81 LMNA (0.47) KDM4ECYP2C19ALDH1A1HPGDUSP2
SCHEMBL1743420 0.80 KDM4E (0.59) KDM4ECYP2C19ALDH1A1HPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE UBE INDUSTRIES, LTD. (JP) 2015-12-24 US disclosed
US-8524715-B2 Phenoxyacetic acid derivatives useful for treating respiratory diseases ASTRAZENECA AB (SE) 2013-09-03 US disclosed
EP-1817282-B1 PHENOXYACETIC ACID DERIVATIVES USEFUL FOR TREATING RESPIRATORY DISEASES ASTRAZENECA AB (SE) 2011-07-20 EP disclosed
US-20090149448-A1 Phenoxyacetic Acid Derivatives Useful for Treating Respiratory Diseases ASTRAZENECA AB (SE) 2009-06-11 US disclosed
EP-1817282-A1 PHENOXYACETIC ACID DERIVATIVES USEFUL FOR TREATING RESPIRATORY DISEASES AstraZeneca AB (SE) 2007-08-15 EP disclosed
WO-2006056752-A1 PHENOXYACETIC ACID DERIVATIVES USEFUL FOR TREATING RESPIRATORY DISEASES ASTRAZENECA AB (SE) 2006-06-01 WO disclosed
EP-1077701-A4 ANTI-VIRAL COMPOUNDS LILLY CO ELI (US) 2002-03-20 EP disclosed
EP-1077701-A1 ANTI-VIRAL COMPOUNDS ELI LILLY AND COMPANY (US) 2001-02-28 EP disclosed
WO-1999059587-A1 ANTI-VIRAL COMPOUNDS ELI LILLY AND COMPANY (US) 1999-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE HCN2, SCO2, HCN1 KDM4E 1067/4885CYP2C19 2227/4885ALDH1A1 1059/4885
US-20090149448-A1 Phenoxyacetic Acid Derivatives Useful for Treating Respiratory Diseases PAOX, PCCA, PAH KDM4E 1277/4885CYP2C19 107/4885ALDH1A1 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.